Table 1.
Patient information and sample use.
| Patient | Age | Gender | Cohort | Analysis |
|---|---|---|---|---|
| 1 | NA | F | BA | Ex vivo flow cytometry |
| 2 | NA | M | BA | Ex vivo flow cytometry |
| 3 | NA | F | BA | Ex vivo flow cytometry |
| 4 | NA | F | BA | Ex vivo flow cytometry |
| 6 | NA | F | BA | Ex vivo flow cytometry |
| 7 | 51 | M | BA | Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 8 | 40 | M | BA | Ex vivo flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 9 | 40 | F | BA | Ex vivo flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 10 | 63 | F | BA | Ex vivo flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 11 | 51 | F | BA | Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 12 | 36 | M | BA | Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 13 | 40 | F | BA | Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 14 | 60 | F | BA | Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 15 | 44 | M | BA | Ex vivo flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 16 | NA | F | BA | Ex vivo flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 17 | 53 | M | BA | Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation, microarray |
| 18 | 45 | F | BA | Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation, microarray |
| 20 | 59 | M | BA | Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 21 | 60 | F | BA | Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 22 | 38 | M | BA | In vitro lymphoproliferation |
| 23 | 59 | F | BA | In vitro lymphoproliferation |
| 24 | 56 | F | BA | In vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation, microarray |
| 25 | 49 | F | BA | In vitro apoptosis |
| 26 | 57 | M | BA | In vitro apoptosis |
| 27 | 49 | F | BA | In vitro flow cytometry, in vitro apoptosis in vitro lymphoproliferation |
| 28 | 60 | M | BA | In vitro flow cytometry, in vitro apoptosis in vitro lymphoproliferation, microarray |
| 29 | 46 | M | BA | In vitro apoptosis, in vitro lymphoproliferation, microarray |
| 31 | 50 | M | BA | In vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation, microarray |
| 32 | 50 | F | BA | In vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation, microarray |
| 33 | 62 | F | BA | In vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation |
| 2,569 | 27 | F | LI | In vitro apoptosis |
| 2,570 | 50 | F | LI | In vitro apoptosis |
| 2,574 | 35 | F | LI | In vitro apoptosis |
| 2,817 | 64 | F | LI | Ex vivo flow cytometry |
| 2,819 | 32 | F | LI | Ex vivo flow cytometry |
| 2,821 | 63 | F | LI | Ex vivo flow cytometry |
| 2,822 | 50 | F | LI | Ex vivo flow cytometry |
| 2,823 | 64 | M | LI | Ex vivo flow cytometry |
| SP5 | 32 | F | SP | Ex vivo flow cytometry |
| SP6 | 65 | F | SP | Ex vivo flow cytometry |
| SP7 | 62 | F | SP | Ex vivo flow cytometry |
| SP8 | 47 | F | SP | Ex vivo flow cytometry |
| SP26 | 35 | M | SP | Ex vivo flow cytometry |
| SP30 | 72 | M | SP | Ex vivo flow cytometry |
| SP32 | 27 | M | SP | Ex vivo flow cytometry |
| SP36 | 52 | F | SP | Ex vivo flow cytometry |
| SP46 | 61 | F | SP | Ex vivo flow cytometry |
Cohorts: BA, Bahia; LI, Lima; SP, Sao Paulo.
NA, not available.